Darusentan Completed Phase 3 Trials for High Blood Pressure (Hypertension) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00330369DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension
NCT00389779DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension